Effect of combined lipid-lowering therapy on atherosclerotic plaque vulnerability in patients with acute coronary syndrome (Combi-LLT ACS): randomized trial protocol

Aim. To study the effect of high-dose combined lipid-lowering therapy (statins + ezetimibe vs statins + PCSK9 inhibitors) on plaque vulnerability assessed using multimodal imaging (coronary computed tomography angiography (CCTA) and optical coherence tomography, as well as biomarkers in patients wit...

Full description

Saved in:
Bibliographic Details
Main Authors: A. N. Kovalskaya, G. R. Bikbaeva, D. V. Duplyakov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2022-12-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5282
Tags: Add Tag
No Tags, Be the first to tag this record!